Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-23T16:13:28.354Z Has data issue: false hasContentIssue false

Chapter 13 - Symptomatic treatment and nutrition

from Part III - Management and therapy

Published online by Cambridge University Press:  05 October 2010

Jürg Kesselring
Affiliation:
Rehabilitation Center Valens, Switzerland
Get access

Summary

INTRODUCTION

A chronic disease such as MS, the etiology of which is unclear, precludes the possibility of causal therapy. On the other hand, this disease encompasses a wide range of symptoms, clinical signs, and associated complications, providing a great challenge for the treating neurologist or physician. The first chapter in this section attempts to describe some of the most important aspects of symptomatic treatments available for patients suffering from MS. In surveying treatment options, measures such as physiotherapy and occupational therapy, as well as drug treatment, will be discussed. All of these measures can be unified under the heading of rehabilitation. In this context, the concept of rehabilitation should not be viewed too narrowly, attempting only to restore sensorimotor functions and the capacity to work. Comprehensive rehabilitation referred to here aims at the improvement, restoration, and maintenance of patients' overall quality of life, and maximum independence in all activities of daily living within their normal social environment.

As experience with, and advances in palliative treatment of, MS have expanded, life expectancy and quality of life of patients have markedly improved. In the past, disturbances caused by the disease and its accompanying complications, for example respiratory weakness and pneumonia, urinary tract infections and renal failure, decubital ulcers and sepsis, often led to premature death. In recent times, however, the use of chemotherapy or antibiotics, as well as determined combating of disease-induced inactivity, have allowed for the control or prevention of such life-threatening complications.

Type
Chapter
Information
Multiple Sclerosis , pp. 135 - 147
Publisher: Cambridge University Press
Print publication year: 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×